| YANA - YOU ARE NOT ALONE NOW PROSTATE CANCER SUPPORT SITE HOMEPAGE LINKS : EXPERIENCES : DISCUSSION FORUM : TROOP C : ABOUT US : JOIN US : UPDATE YOUR STORY : MAIL US Acknowledgment and thanks are due to Eric Taylor, Australian Mentor for YANA, who created this and the other Charts. | |||||||||||||
TREATMENT CHOICES INDEXED BY - PSA AT DIAGNOSIS
| Many people are looking for information about the treatment choices made by men with a similar diagnosis to theirs , so the stories on this page are indexed by PSA AT DIAGNOSIS. There are OTHER INDEXES: For ease of access the PSA indexed stories are then grouped as:
The stories are are also indexed by
It is also possible to see some of the stories indexed by country, or, in the case of the USA, the State of residence. The link is PLACE NAME TABLE The accounts on the site are based on information received from our contributors and they may not be completely accurate.We hope they may provide you with an insight into how others have dealt with the issues that you now face. The stories and charts provided are for your information only, and show a brief summary of what others have done. They should not be used for making your own treatment decision. Please be aware that there is much more to the decision making process, as you will see if you go to CHOOSING A TREATMENT. | ||||||||||||
|
THIS INDEX IS SORTED BY PSA AT DIAGNOSIS. THIS SECTION LISTS MEN WITH A PSA GREATER THAN 10.0 NG/ML AND LESS THAN 20.0 NG/ML Click on the man's name to read his personal story and his treatment choice. Go to PSA INDEX for other PSA levels. | |||||||||||||
|
Primary
Treatment |
Further
treatment, if any, with current PSA |
Name | |||||||||||
| Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
| Feb-92 |
68 |
10.2 |
5 |
B2 |
Surgery |
Passed
On - RIP | Jul-08 | ||||||
Sep-06 | 45 | 10.2 | 9 | T2c | Surgery/ADT/EBRT | No
response to reminder | Aug-08 | ||||||
Aug-04 | 44 | 10.4 | 6 | T1c | Surgery/ADT | Undetec | - | May-09 | |||||
May-08 | 71 | 10.4 | 7 | T1c | Proton
Beam | 3.44
| No
side effects | Feb-10 | |||||
Jan-09 | 52 | 10.4 | 7 | T2a | LR
Surgery | - | - | Jun-09 | |||||
Apr-09 | 57 | 10.4 | 6 | T1c | LR
Surgery | Undetec | - | Oct-09 | |||||
| Nov-04 |
58 |
10.4 |
6 |
T1b |
Brachytherapy |
0.10 |
No
problems |
Jan-10 | |||||
Dec-04 | 70 | 10.5 | 7 | T1c | EBRT | 3.2 | - | Aug-09 | |||||
Dec-08 | 73 | 10.5 | 9 | T1c | Brachytherapy/ADT | - | - | Jan-09 | |||||
Jan-09 | 61 | 10.5 | 6 | T1c | Active
Surveillance | 16.4 | Herbs
and diet | Aug-10 | |||||
|
Jul-04 |
67 |
10.5 |
6 |
T1c |
LR
Surgery |
No
response to reminder |
Dec-07 | ||||||
Oct-07 | 55 | 10.5 | 6 | T1c | Surgery | Undetec | Some
laugh leakage | Dec-09 | |||||
Jun-05 | 57 | 10.7 | 7 | T1c | Surgery | 0.03 | Had
strictures | Feb-10 | |||||
Nov-08 | 55 | 10.8 | 9 | T1c | LR
Surgery | Undetec | Severe
ED | Jan-10 | |||||
Mar-05 | 64 | 10.9 | 6 | T1c | LR
Surgery | Undetec | - | Sep-09 | |||||
Mar-10 | 52 | 10.9 | 7 | T1c | Undecided | - | - | Jun-10 | |||||
Sep-04 | 52 | 10.9 | 6 | T1c | LR
Surgery | Undetec | Chemo/ADT
trial | Dec-09 | |||||
Jul-10 | 59 | 11.0 | 8 | T1c | Undecided | - | - | Aug-10 | |||||
Jun-05 | 67 | 11.0 | 6 | T2c | HDR
Brachytherapy | <0.05 | - | Oct-09 | |||||
Jan-98 | 76 | 11.0 | 6 | T1c | Watch
& Wait | Passed
on - RIP | Jul-00 | ||||||
Jul-01 | 56 | 11.0 | 7 | T2a |
Surgery | 3.82 | EBRT/ADT | Oct-09 | |||||
Jun-05 | 78 | 11.1 | 7 | T2c | Hormone | 0.10 | Hormone | Jun-09 | |||||
Jul-08 | 50 | 11.1 | 6 | T1c | LR
Surgery | <0.10 | ED
and leakage | Mar-10 | |||||
Mar-97 | 42 | 11.2 | 9 | T1c | Surgery | Passed
On - RIP | Jun-07 | ||||||
|
Apr-05 |
61 |
11.2 |
9 |
T3 |
Surgery |
0.01 |
Orchidectomy |
Mar-10 | |||||
Nov-08 | 68 | 11.2 | 5 | T1c | ADT/EBRT | - | - | Aug-09 | |||||
|
Oct-03 |
67 |
11.2 |
? |
T1c |
Surgery |
4.3 |
EBRT/ADT |
Mar-10 | |||||
|
Jul-05 |
60 |
11.2 |
6 |
T1c |
Proton
Beam | 0.59 |
Some
ED issues |
Dec-09 | |||||
Mar-07 | 67 | 11.3 | 6 | T1c | Brachytherapy | 1.10 | Urinary
probs gone | Jun-10 | |||||
Aug-09 | 61 | 11.5 | 6 | T1c | LR
Surgery | - | - | Oct-09 | |||||
Nov-06 | 57 | 11.5 | 7 | T2 | Proton
Beam | 1.3 | - | Oct-09 | |||||
|
Dec-04 |
48 |
11.6 |
9 |
T2c |
ADT/EBRT |
0.32 |
Intermit
ADT |
Oct-09 | |||||
Feb-09 | 64 | 11.6 | 6 | T1c | 10.8 | Active
Surveillance | Mar-10 | ||||||
Oct-08 | 54 | 11.8 | 6 | T2a | Proton
Beam | 5.4 | No
S/E reported | Jun-10 | |||||
May-08 | 54 | 11.8 | 8 | T1c | Surgery | No
response to reminder | Oct-08 | ||||||
Sep-09 | 54 | 12.0 | 6 | T1c | Undecided | - | - | Sep-09 | |||||
Oct-02 | 55 | 12.0 | ? | T1c | ADT/EBRT | +-5.0 | Intermittent
ADT | Feb-10 | |||||
Oct-04 | 54 | 12.0 | 7 | T1c | Surgery | 0.20 | EBRT/ADT/Chemo | Jul-10 | |||||
May-07 | 65 | 12.0 | 9 | T1c | EBRT/ADT | 0.09 | Int
ADT/Rad Dam | Jul-10 | |||||
May-06 | 59 | 12.0 | 9 | ? | EBRT/ADT | - | Tiredness/ED | Nov-09 | |||||
Dec-05 | 66 | 12.1 | 6 | T1c | LR
Surgery | Undet | ED | Jun-10 | |||||
Jan-06 | 58 | 12.1 | 6 | T1c | Surgery |
0.08 |
ED | Jan-10 | |||||
May-07 | 70 | 12.2 | 6 | T1c | ADT/Radiation | 0.01 | Inter
ADT: ED | Aug-10 | |||||
May-07 | 52 | 12.2 | 6 | T1c | Active
Surveillance | 37.0 | - | May-09 | |||||
|
May-05 |
56 |
12.5 |
8 |
T1c |
Surgery |
Undetec |
EBRT/ADT/Diet |
Jun-10 | |||||
| Dec-08 |
56 |
12.5 |
8 |
T1c |
LR
Surgery | - |
- |
May-09 | |||||
Jun-09 | 58 | 12.5 | 6 | T1c | Active
Surveillance | 5.2 | - | Oct-09 | |||||
Aug-96 | 69 | 12.5 | 5 | T1c | EBRT | No
response to reminder | Jan-08 | ||||||
Feb-07 | 64 | 12.6 | 6 | T1c | Surgery/EBRT/ADT | Undetec | Intermit
ADT/Bladder Ca | Mar-10 | |||||
Jun-07 | 51 | 12.6 | 7 | T2c | LR
Surgery | Undetec | ED
issues | Jun-10 | |||||
Jul-06 | 67 | 12.8 | 6 | T1c | Active
Surveillance | 4.5 | Cancer
Free | Dec-09 | |||||
| Apr-09 |
53 |
12.89 |
8 |
T1c |
LR
Surgery | - |
- |
Aug-09 | |||||
Sep-09 | 72 | 13.0 | 9 | T1c | Proton
Beam | - | - | Dec-09 | |||||
Dec-07 | 70 | 13.0 | 7 | T1c | LR
Surgery | Undetec | - | Jun-09 | |||||
May-09 | 46 | 13.0 | 6 | T1c | Surgery | - | - | Jun-09 | |||||
Dec-08 | 65 | 13.0 | 8 | T4 | ADT
| 0.14 | EBRT/Brachytherapy | Nov-09 | |||||
Dec-06 | 57 | 13.0 | 7 | T1c | Surgery | 0.01 | Caverject
for ED | Oct-09 | |||||
Jan-07 | 66 | 13.1 | 9 | T3a | Surgery | 0.008 | Some
ED/Incont | Jun-10 | |||||
Oct-08 | 62 | 13.1 | 7 | T1c | Surgery | 0.02 | ED
issues | Apr-10 | |||||
Sep-09 | 74 | 13.1 | 7 | T1c | LR
Surgery | 2.1 | ADT/EBRT | Jun-10 | |||||
May-06 | 72 | 13.1 | 6 | T1c | ADT/Radiation | 1.22 | Off
period ADT | Dec-09 | |||||
Aug-04 | 50 | 13.4 | 7 | T1c | Surgery | Undetec | - | Oct-09 | |||||
Mar-09 | 67 | 13.6 | 8 | T3 | LR
Surgery/ADT | Undetec | ADT
- no libido | Jan-10 | |||||
| Feb-09 |
60 |
13.6 |
7 |
T2a |
Proton
Beam | 5.7 |
- |
Oct-09 | |||||
Jul-06 | 59 | 13.7 | 6 | T1c | Surgery | Undetec | ED
& Incontinence | Dec-09 | |||||
Nov-05 | 57 | 13.7 | 8 | T1c | Surgery | 0.70 | ADT | Jun-10 | |||||
Apr-10 | 60 | 14.0 | 6 | T1c | Undecided | - | - | Jun-10 | |||||
| Jun-04 |
45 |
14.0 |
7 |
T2b |
Surgery
| 1.40 |
EBRT:
ED issues |
Jul-10 | |||||
| Apr-96 |
56 |
14.0 |
4 |
T1c |
Surgery |
0.50 |
Intermittent
ADT |
Sep-09 | |||||
|
Apr-97 |
58 |
14.0 |
5 |
T1c |
Surgery |
Undetec |
100%
ED | Jun-10 | |||||
| Oct-09 |
63 |
14.1 |
6 |
T1c |
Active
Surveillance | 14.3 |
Cancer
free |
Jan-10 | |||||
Oct-01 | 46 | 14.4 | 7 | T2 | Surgery | 0.10 | EBRT/ADT | Jan-10 | |||||
Nov-98 | 68 | 14.6 | 6 | T1c | ADT | 0.25 | Inter
ADT: POM juice | Sep-10 | |||||
|
Nov-91 |
57 |
14.7 |
7 |
T3c |
Surgery |
0.95 |
Intermittent
ADT | Jan-09 | |||||
| Apr-94 |
76 |
15.0 |
6 |
T2b |
Radiation/Cryo/ADT |
Passed
On - RIP | Jun-07 | ||||||
Aug-06 | 57 | 15.0 | 5 | T1a | Active
Surveillance | 0.30 | Finasteride | Aug-09 | |||||
Mar-05 | 53 | 15.0 | 5 | T2a | Manual
Lap Surgery | <0.10 | Some
ED/incont | Mar-10 | |||||
Jun-08 | 57 | 15.0 | 6 | T1c | Proton
Beam | 11.5 | - | Jan-09 | |||||
Mar-03 | 54 | 15.0 | ? | ? | Surgery | ? | - | Jul-09 | |||||
Jan-10 | 59 | 15.1 | 7 | T1c | Undecided | - | - | Feb-10 | |||||
Jan-10 | 50 | 15.7 | 6 | T1c | EBRT
- Calypso® | 10.2 | - | Jul-10 | |||||
Jun-05 | 50 | 15.77 | 7 | T2b | Surgery | Undetec | EBRT/ADT:
ED | Jun-10 | |||||
|
Jun-02 |
62 |
15.9 |
7 |
T2 |
Radiation |
<0.01 |
Diet
- no SE |
Dec-09 | |||||
Jan-96 | 57 | 16.0 | 8 | ? | Surgery | <7.0
| Inter
ADT | Oct-09 | |||||
Nov-00 | 46 | 16.0 | 7 | T1c | Surgery | Undetec | ADT | Jun-09 | |||||
Feb-09 | 62 | 16.0 | 7 | T2 | LR
Surgery | - | - | Apr-09 | |||||
Sep-09 | 53 | 16.0 | 6 | T1c | Surgery | - | - | Jan-10 | |||||
May-08 | 71 | 16.0 | ? | T3 | ADT
| - | ADT | Aug-09 | |||||
Apr-07 | 61 | 16.2 | 7 | T2b | Surgery(Failed) | 14.0
| Alternative
meds | Aug-10 | |||||
Jan-06 | 60 | 17.0 | 7 | T1c | Surgery/EBRT | - | Incontinent
- AUS | Dec-09 | |||||
Feb-06 | 62 | 17.0 | 7 | T3 | ADT/EBRT | 0.31 | ADT | Apr-09 | |||||
|
Mar-00 |
56 |
17.4 |
7 |
T2b |
Surgery |
Undetec |
EBRT
- no SE listed |
Mar-10 | |||||
|
Jan-01 |
63 |
17.7 |
6 |
T1c |
Surgery |
<0.05 |
Monitoring |
Dec-09 | |||||
Dec-06 | 56 | 17.8 | 9 | T2a | Surgery/EBRT/ADT | 1.5 | Chemotherapy | May-09 | |||||
Jun-08 | 68 | 18.0 | 9 | T1c | ADT/HIFU | 0.10 | ADT | Jan-10 | |||||
Sep-08 | 58 | 18.0 | 8 | T1c | ADT/EBRT | 2.5 | Loss
of ejaculate | Jul-10 | |||||
Aug-06 | 52 | 18.7 | 9 | T2c | ADT/EBRT | 0.14 | Intermit
ADT | Jul-10 | |||||
May-06 | 61 | 18.9 | 7 | T1c | Surgery | 0.03 | EBRT/ADT
- holiday | Jun-10 | |||||
May-05 | 59 | 19.0 | 7 | T2c | ADT/Radiation | Passed
On - RIP | Jan-09 | ||||||
Aug-94 | 70 | 19.0 | 9 | T1c | EBRT/ADT | 11.1 | ADT | Apr-10 | |||||
Feb-08 | 64 | 19.0 | 7 | T1c | IMRT | 0.39 | - | Oct-09 | |||||
Mar-07 | 56 | 19.0 | 6 | T1c | Watchful
Waiting | 6.5 | Alkaline
Diet | Jun-10 | |||||
Sep-08 | 46 | 19.3 | 6 | T1c | 0.90 | Active
Surveillance | Jan-10 | ||||||
Jun-07 | 51 | 19.5 | 7 | T2 | ADT/IMRT/Brachy
HDR | 6.14 | Estrogen | Aug-09 | |||||
| Mar-00 |
57 |
19.8 |
5 |
T1c |
Surgery |
166.0 |
EBRT/ADT |
Aug-10 | |||||
Oct-06 | 44 | 19.8 | 7 | T2a | LR
Surgery /ADT/EBRT | Undetec |
ADT holiday | Aug-10 | |||||
Jun-07 | 61 | 19.8 | 6 | T1c | Intermit
ADT3 | 9.84 | Alt
therapies | Sep-10 | |||||
Jan-94 | 58 | 20.0 | 5 | T2 | Active
Surveillance | Rising | Change
Lifestyle | May-09 | |||||
|
THIS INDEX IS SORTED BY PSA AT DIAGNOSIS. THIS SECTION LISTS MEN WITH A PSA GREATER THAN 20.0 NG/ML Click on the man's name to read his personal story and his treatment choice. Go to PSA INDEX for other PSA levels. | |||||||||||||
|
Primary
Treatment |
Further
treatment, if any, with current PSA |
Name | |||||||||||
| Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment
| Date | ||||||
| Jun-09 |
40 |
20.2 |
10 |
T4 |
LR
Surgery | Undetec |
EBRT/ADT/Chemo |
Aug-10 | |||||
Nov-07 | 65 | 20.2 | 6 | T3 | ADT/EBRT | 0.10 | No
problems reported | Aug-10 | |||||
Jun-08 | 62 | 20.3 | 7 | T1c | LR
Surgery | Undetec | - | Sep-09 | |||||
| Nov-01 |
54 |
20.4 |
8 |
T3b |
Surgery | <0.01 | ADT/Chemo | Jul-10 | |||||
Jun-08 | 68 | 20.8 | 8 | T3 | ADT/EBRT/Brachy | 0.20 | ADT | Jun-10 | |||||
Jun-09 | 54 | 21.0 | 6 | T1c | Undecided | - | - | Jan-10 | |||||
Feb-07 | 59 | 21.0 | 9 | T1c | Surgery | Undetec | EBRT/ADT | May-09 | |||||
|
Dec-03 |
56 |
21.0 |
9 |
T2c |
HDR
Brachytherapy |
0.06 |
ADT |
Mar-10 | |||||
| Jul-00 |
62 |
21.5 |
6 |
T1c |
ADT/ProstRcision© |
0.10 |
Flomax |
Oct-09 | |||||
Feb-08 | 53 | 21.8 | 7 | T1c | Surgery | Undetec | EBRT | Jan-10 | |||||
Feb-04 | 65 | 22.0 | 8 | T2b | EBRT/ADT | 0.06 | Intermit
ADT3 | Sep-09 | |||||
Jan-08 | 65 | 22.0 | 8 | T3 | LR
Surgery | 9.7 | ADT | Apr-09 | |||||
Jan-09 | 57 | 22.5 | 10 | T4 | ADT | 3.3 | ADT/Diet | Jul-10 | |||||
Jan-06 | 58 | 22.9 | 8 | T1c | EBRT/ADT | 0.20 | Intermit
ADT | Sep-09 | |||||
| Nov-07 |
56 |
23.0 |
9 |
T2c |
IMRT/ADT |
0.04 |
Intermit
ADT | Nov-09 | |||||
Jun-00 | 57 | 23.0 | 7 | T1c | Surgery | 2.4 | EBRT/ADT:
ED: implant | Jul-10 | |||||
Jun-09 | 56 | 23.2 | 6 | T1c | LR
Surgery | 0.01 | Incontinence
and ED | Jul-10 | |||||
Mar-09 | 78 | 23.4 | 9 | T1c | ADT
(Eligard) | 1.4 | - | Jun-09 | |||||
Jun-07 | 61 | 24.0 | 7 | T3b | ADT/EBRT | - | - | Aug-09 | |||||
Apr-08 | 55 | 24.0 | 8 | T1c | Surgery | 1.4 | ADT/EBRT:metastases
| Jul-10 | |||||
Jul-06 | 72 | 24.0 | 10 | T3 | ADT |
Passed
On - RIP | Aug-10 | ||||||
Aug-05 | 61 | 24.0 | 8 | T4M | ADT
| 1.90 | ADT/Natural | Jun-10 | |||||
Jul-10 | 78 | 25.33 | 7 | T1c | Undecided | - | - | Aug-10 | |||||
Sep-96 | 57 | 25.4 | 7 | T2c | ADT/EBRT/HIFU |
No
response to reminder | Jun-08 | ||||||
Jan-07 | 66 | 25.7 | 7 | T3 | Intermittent
ADT | 8.29 |
ADT/EBRT | Jul-10 | |||||
| Aug-04 |
44 |
27.0 |
? |
T1c |
Brachytherapy |
- |
ADT/Surgery |
Jun-10 | |||||
Oct-98 | 72 | 27.4 | 7 | T3b | ADT/Radiation | 11.0 | Inter
ADT - holiday | Jun-10 | |||||
Oct-07 | 54 | 27.5 | 7 | T1c | ADT | 1.4 | ADT/EBRT/Chemo | Aug-09 | |||||
Nov-02 | 58 | 28.0 | 9 | T2c | ADT/EBRT(IMRT)/Brach | <0.003 | - | Dec-09 | |||||
Oct-06 | 53 | 29.0 | 7 | T1c | ADT/EBRT/Brachy | 0.31 | Intermit
ADT | Sep-09 | |||||
Mar-04 | 49 | 29.48 | 7 | T2c | ADT/EBRT/Brachy | 0.10 | Viagra
helps ED | Dec-09 | |||||
Mar-08 | 55 | 30.0 | 9 | T4 | ADT | 1.14 | ADT | Sep-09 | |||||
Apr-09 | 55 | 31.0 | 9 | T1c | Surgery | Undetec | - | Jul-09 | |||||
Jun-07 | 63 | 31.0 | 8 | T1c | Brachy/ADT/EBRT | <0.05
| No
SE mentioned | Jul-10 | |||||
Apr-07 | 45 | 31.0 | 8 | T4 | ADT/Radiation | Passed
On - RIP | Dec-09 | ||||||
Sep-07 | 65 | 31.0 | 7 | T2b | LR
Surgery | 0.66 | ADT/EBRT | Aug-10 | |||||
Jan-05 | 47 | 31.19 | 7 | T1c | Radiation/ADT | 1.06 | Inter
ADT | Aug-09 | |||||
Oct-00 | 64 | 32.0 | 7 | T1c | Surgery | 0.90 | EBRT/ADT
- 3 yr holiday | Jul-10 | |||||
Feb-99 | 53 | 32.0 | 6 | T1c | ADT/EBRT | 4.5 | Cryotherapy:ED
| Aug-10 | |||||
May-04 | 50 | 33.9 | 9 | T2c | Surgery | No
response to reminder | Apr-08 | ||||||
Oct-07 | 54 | 34.0 | 7 | T1c | EBRT | 0.93 | No
problems reported | Jun-10 | |||||
| Jun-06 |
55 |
34.0 |
9 |
T2c |
ADT/HDR
Brachy/EBRT |
105.0 |
Clinical
trial | Jan-10 | |||||
Sep-06 | 82 | 35.0 | ? | T1c | ADT
(Orchiectomy) | No
response to reminder | Sep-08 | ||||||
Jun-08 | 66 | 35.0 | 7 | T1c | ADT/LR
Surgery | <0.05 | - | Jun-10 | |||||
Aug-04 | 54 | 36.0 | 7 | T1c | SI/EBRT
ProstRscision | 0.20 | - | Jul-09 | |||||
Oct-06 | 51 | 36.6 | 6 | T1c | ProstRcision® | 0.08 | None | Jan-10 | |||||
Nov-07 | 69 | 37.8 | 9 | T1c | ADT/Radiation | <0.10 | ADT | Aug-09 | |||||
Nov-06 | 50 | 38.0 | 8 | T1c | ADT/EBRT/Brachy | 0.30 | Intermit
ADT - holiday | Aug-10 | |||||
| Nov-09 |
47 |
38.0 |
7 |
T3c |
ADT/EBRT |
0.26 |
ED |
Aug-10 | |||||
Mar-09 | 65 | 39.0 | 7 | T2a | EBRT
| 0.20 | - | Aug-09 | |||||
Sep-04 | 59 | 39.0 | 7 | T1c | EBRT | 420.0 | ADT | Sep-09 | |||||
Oct-08 | 63 | 40.0 | 7 | T1c | ADT/Brachy/IMRT | Undetec | ADT
holiday | Jul-10 | |||||
Oct-08 | 40 | 41.0 | 8 | T4 | ADT | <
1.0 | Surgery/ADT | Jul-10 | |||||
Feb-05 | 63 | 42.0 | 9 | T4 | ADT | 2.2 | TAK700
Trial | Nov-09 | |||||
Nov-08 | 72 | 42.0 | 8 | T1c | ADT/EBRT | - | - | Jan-09 | |||||
|
Jun-09 |
69 |
42.0 |
8 |
T4 |
ADT/EBRT | - | ADT |
Oct-09 | |||||
|
Nov-09 |
43 |
46.0 |
6 |
T1c |
LR
Surgery | - |
Surgery
abandoned |
Jan-10 | |||||
Jul-02 | 51 | 46.0 | 7 | T2 | Surgery | 0.10 |
ADT - MRI scan clear | Apr-10 | |||||
|
Mar-02 |
51 |
46.0 |
9 |
T2 |
IMRT/ADT |
0.75 |
Intermit
DES | Jun-10 | |||||
Apr-09 | 72 | 47.0 | 9 | T4 | ADT | - | - | May-09 | |||||
Jan-07 | 61 | 48.0 | ? | ? | ADT/EBRT | 0.05 | ADT/ED | Mar-10 | |||||
Dec-01 | 72 | 48.0 | 7 | T1c | EBRT/ADT | 50.0 | No
funds:no treatment | Mar-10 | |||||
Nov-06 | 62 | 48.0 | 7 | T1c | ADT/IMRT | 6.54 | Orchidectomy/ADT | Aug-09 | |||||
Jan-09 | 59 | 53.0 | 7 | T1c | EBRT(IMRT) | 0.30 | Inter
ADT | Dec-09 | |||||
Dec-06 | 55 | 53.0 | ? | T4 | ADT/EBRT | <1.0 | ED | Jan-10 | |||||
Sep-03 | 69 | 57.0 | 7 | T4 | ADT | Passed
On - RIP | Jun-08 | ||||||
Nov-95 | 48 | 60.0 | 7 | T1c | Watch/Wait | Passed
On - RIP | Sep-07 | ||||||
Dec-06 | 54 | 60.0 | 6 | T1c | EBRT | 1.3 | Intermit
ADT | Aug-09 | |||||
Apr-10 | 59 | 61.3 | 7 | T1c | Surgery | - | - | Jun
-10 | |||||
Sep-07 | 64 | 62.3 | 9 | T3 | ADT | 1.20 | EBRT/ADT | Aug-10 | |||||
Jan-07 | 65 | 63.0 | 8 | T2a | EBRT/Brachy | 0.028 | Intermit
ADT | Dec-08 | |||||
Oct-06 | 46 | 63.0 | 7 | T4M1 | ADT | Chemo
failed - mets spread | Jun-10 | ||||||
Nov-07 | 50 | 66.04 | 7 | T3b |
ADT/EBRT | 0.54 | Intermit
ADT | Feb-09 | |||||
Sep-08 | 39 | 68.0 | 9 | T4 | ADT
| <0.40 | ADT | Oct-09 | |||||
Jun-08 | 58 | 70.0 | 7 | T1c | LR
Surgery | 0.37 | EBRT/ADT:ED/Mets:Trial | Sep-10 | |||||
May-06 | 57 | 70.0 | 10 | T3 | ADT | 0.05 | Intermit
ADT | Oct-09 | |||||
May-07 | 56 | 76.41 | 9 | T3b | EBRT/ADT | 0.09 |
ADT holiday | Jun-10 | |||||
| Dec-93 |
58 |
78.0 |
6 |
T3c |
EBRT/ADT |
1.65 |
ADT++ |
Aug-08 | |||||
|
Sep-09 |
46 |
80.0 |
8 |
T3 |
ADT |
5.0 |
ADT |
Jul-09 | |||||
Dec-03 | 52 | 80.3 | 8 | T3/T4 | ADT/Surgery | Undetec | ADT3 | Jan-10 | |||||
Jan-08 | 63 | 91.6 | 9 | T4 | ADT | 0.05 | ADT | Aug-09 | |||||
|
May-91 |
60 |
92.0 |
6 |
T2c |
Surgery |
24.0 |
Watch&Wait |
Jul-10 | |||||
Apr-08 | 58 | 98.0 | 8 | T4 | ADT | 42.0 | ADT/EBRT/Chemo | Sep-10 | |||||
Aug-07 | 54 | 98.8 | 7 | T2c | EBRT/ADT | Undetec | Intermit
ADT | Mar-10 | |||||
| Mar-04 |
66 |
108.0 |
8 |
T3b |
ADT/Surgery
| 0.19 |
EBRT |
Dec-09 | |||||
Jan-96 | 58 | 110.0 | 7 | T4 | ADT | 3.6
| Inter
ADT/Chemo | Jul-10 | |||||
Jan-09 | 70 | 114.0 | 7 | T2 |
ADT/EBRT | 0.30 | ADT | Jul-10 | |||||
May-07 | 59 | 115.0 | 7 | T2a | ADT/Brachytherapy | 4.2 | EBRT | Oct-09 | |||||
Apr-08 | 63 | 127.0 | ? | T4 | ADT | Passed
On - RIP | Sep-09 | ||||||
Jun-05 | 57 | 133.0 | 7 | T3a | ADT/EBRT | Passed
On - RIP | Jun-10 | ||||||
Dec-06 | 51 | 139.0 | 7 | T4 | ADT/EBRT | 22.9 | Intermit
ADT | Jul-10 | |||||
Oct-08 | 67 | 141.0 | 8 | T4 | ADT | 8.8 | ADT | Jul-09 | |||||
|
Dec-96 |
68 |
145.0 |
7 |
T4 |
Radiation |
60 ish |
Chemotherapy |
Apr-09 | |||||
Jan-08 | 52 | 146.0 | 9 | T4 | ADT | 18.5 | Intermittent/Diet | Mar-10 | |||||
May-09 | 59 | 150.0 | 7 | T4 | ADT | - | - | Aug-10 | |||||
Feb-08 | 51 | 153.0 | 7 | T3b | ADT | 40.0
| Clinical
Trial - Degarelix | Mar-10 | |||||
Sep-08 | 48 | 158.0 | 7 | T3a | Surgery/EBRT/ADT | 0.25 | Incontinence/ED | Nov-09 | |||||
Mar-09 | 50 | 179.0 | ? | T4 | ADT | 0.05
| - | Jan-10 | |||||
Apr-05 | 54 | 182.0 | 6 | T4 | ADT/Radiation | 5.87 |
ADT holiday/Diet | Jun-10 | |||||
| Jan-05 |
50 |
206.6 |
9 |
T3 |
Hormone | Passed
On - RIP | Nov-08 | ||||||
Feb-05 | 42 | 219.0 | 8 | T4 | ADT | 88.0 | Chemotherapy | Aug-09 | |||||
Jun-07 | 54 | 220.0 | 6 | T1c | ADT | Passed
On - RIP | Nov-08 | ||||||
Apr-04 | 51 | 252.0 | 9 | T3a | ADT/EBRT | 2.20 | Intermit
ADT | Jun-10 | |||||
May-09 | 63 | 286.0 | 8 | T4 | ADT | 0.35 | Signs
of retreat | Jun-10 | |||||
Aug-08 | 62 | 299.0 | ? | T4 | ADT | 1.8 | ADT | Mar-10 | |||||
Jul-07 | 69 | 322.7 | 9 | T4 | ADT | No
response to reminder | Dec-07 | ||||||
Aug-04 | 60 | 333.0 | 9 | T4 | ADT | 2.6 | ADT | Jun-09 | |||||
|
May-09 |
51 |
362.0 |
9 |
T4 |
ADT | 157.0 | ADT3 |
Apr-10 | |||||
Aug-08 | 50 | 375.0 | 8 | D2 | ADT | 420.0 |
Chemotherapy | Nov-09 | |||||
Dec-08 | 56 | 377.0 | 8 | T3 | ADT/EBRT | 0.35 | ADT | Jul-10 | |||||
| Dec-02 |
58 |
421.0 |
8 |
T4 |
Hormone |
0.90 |
Chemotherapy |
Feb-10 | |||||
Mar-06 | 48 | 433.0 | ? | T4 | ADT/Chemotherapy | Passed
On - RIP | Dec-07 | ||||||
Sep-06 | 59 | 435.0 | 9 | T4 | ADT | 734.0 | Chemotherapy | Dec-08 | |||||
Mar-08 | 62 | 459.0 | 9 | T3 | ADT | 217.0 | Chemo/DES/Trial | Aug-10 | |||||
| Jan-09 |
54 |
564.0 |
9 |
T4 |
ADT | 1.0 | ADT |
Aug-09 | |||||
Aug-08 | 58 | 743.9 | 8 | T3 | ADT/EBRT | 0.30 |
ADT | Jan-10 | |||||
Apr-07 | 56 | 960.0 | ? | T4 | ADT | 42.0 | ADT2 | Aug-10 | |||||
Jan-10 | 69 | 1,000+ | ? | T4 | ADT | 68.0 | ADT | Mar-10 | |||||
Dec-07 | 65 | 1,121.0 | 7 | T4 | ADT | 26.0 | Intermit
ADT | Dec-09 | |||||
Dec-08 | 55 | 1,448.0 | ? | T4 | ADT | 13.3 |
ADT/Alternatives | Nov-09 | |||||
Jun-10 | 68 | 1,450.0 | 9 | T1a | ADT/Chemotherapy | 55.0 | No
side effects | Aug-10 | |||||
Dec-08 | 47 | 1,500.0 | 9 | T4 | ADT | 33.4 |
Trial | Sep-09 | |||||
Apr-09 | 75 | 1,892.0 | ? | T4 | ADT/Orchiectomy
| Passed
On - RIP | Mar-10 | ||||||
Dec-08 | 63 | 2,000.0 | 10 | T4 | ADT | 285.0 | ADT/Chemotherapy | Aug-10 | |||||
| Jan-03 |
52 |
2,100.0 |
9 |
T4 |
ADT |
1,002.0 |
Red
Wine/ADT |
Sep-09 | |||||
Nov-08 | 52 | 2,520.0 | 9 | T4 | ADT | 723.0 | Chemotherapy | Jun-10 | |||||
Jun-06 | 42 | 3,216.12 | 7 | T4 | ADT | 6.0 | Intermittent
ADT | Aug-10 | |||||
Sep-06 | 66 | 3,568.0 | ? | T4 | ADT | No
response to reminder | Jan-08 | ||||||
Jul-10 | 55 | 3,970.0 | 6 | T4 | ADT | - | - | Aug-10 | |||||
| Dec-99 |
59 |
4,212.0 |
7 |
T4 |
Hormone | Passed
On - RIP | Aug-09 | ||||||
Jul-08 | 72 | 7,000.0 | 10 | T4 | ADT
| 72.0 | ADT
- ? trial | Jul-10 | |||||